CT Lung Analysis & Lung CAD
CT Lung Analysis* aids in measuring and characterizing lung nodules. The interface and automated tools help to efficiently determine growth patterns and compose comparative reviews.
Key Benefits
- Automated segmentation of lung and airways with expert presets for visualization
- Single-click lung nodule segmentation tools to include solid nodules and ground glass opacity (GGO) nodules
- Quantification of lung nodules with nodule growth and doubling times in comparison studies
- Streamlined workflow transfers lung nodule findings to your site’s existing PowerScribe® 360 deployment
- Additional software offerings (CT Lung Density Analysis, Lung CAD, Visia CT Lung CAD) for Lung Screening Initiatives
Lung CAD
Lung CAD is a computer-aided detection (CAD) system for chest multi-slice CT exams. Lung CAD automatically detects potentially actionable lung nodules from 4 mm to 30 mm in size. Lung nodules detected in Lung CAD can be shown within CT Lung Analysis.
Key Benefits
- Improves technologist’s and radiologist’s workflow by automatically detecting pulmonary nodules in CT images
- Clinically validated CAD performance designed to help improve reader accuracy
Photorealistic view with Global Illumination
Global Illumination is a new revolutionary 3D/4D rendering technique to help provide a more photorealistic view of human anatomy, available within existing Vitrea Advanced Visualization workflows. Global Illumination Rendering (GIR) provides easy to understand images that are excellent for explaining examination results to patients
* Vitrea Advanced Visualization is owned and manufactured by Canon Medical Informatics, Inc.
Lung CAD is a separately licensed feature within the CT Lung Analysis application
Lung CAD is not available in the U.S.
Lung CAD is a separately licensed feature within the CT Lung Analysis application
Lung CAD is not available in the U.S.
Your partner to fight against lung cancer
Lung cancer is one of the most frequent causes of cancer and the leading cause of cancer death globally1. However, when the disease is detected at an early stage, the chances of survival increase dramatically2.
Canon Medical offers a unique set of lung cancer screening solutions. These include a suite of innovative technologies to enhance your clinical confidence everywhere, delivering high-quality imaging at low dose, streamlining workflows, and offering comprehensive diagnosis throughout the entire cycle of care.
1. Globocan 2020
2. Oudkerk M. et al | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology (2021)
Canon Medical offers a unique set of lung cancer screening solutions. These include a suite of innovative technologies to enhance your clinical confidence everywhere, delivering high-quality imaging at low dose, streamlining workflows, and offering comprehensive diagnosis throughout the entire cycle of care.
1. Globocan 2020
2. Oudkerk M. et al | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology (2021)
- Formation et ressources
- Publications (en anglais)
- Formation
- Matériel de cours (site en anglais)
- AICE
- VISIONS Magazine – IA (site en anglais)
- VISIONS Magazine – Radiographie interventionnelle (site en anglais)
- VISIONS Magazine – IRM (site en anglais)
- VISIONS Magazine – Éditions européennes (site en anglais)
